| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |